article thumbnail

Q&A: Looking ahead at digital health, biotech funding in 2023

Mobi Health News

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

BioTech 362
article thumbnail

Why Investors and Media are Calling Biotech Showcase™ “The Place to Be to Start the Year”

Digital Health Global

Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scaling Up For Success: Challenges and Solutions In Upstream Biotech Development

Electronic Health Reporter

Scaling up is a crucial step in the development of biotechnology processes, particularly in upstream biotech development.

BioTech 91
article thumbnail

Bonfire Analytics Raises Oversubscribed $2M Venture Round to Accelerate Digital Health, Medical Device, & Biotech Adoption Across Healthcare Providers

Healthcare IT Today

Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).

BioTech 103
article thumbnail

Biotech company Prothena taps Walgreens to recruit patients for Alzheimer’s drug research

FierceHealthIT

Biotech company Prothena taps Walgreens to recruit patients for Alzheimer’s drug research hlandi Thu, 04/13/2023 - 06:51

BioTech 110
article thumbnail

Benchling gets $14.5M to build collaboration tools for biotechs, pharmas

Mobi Health News

Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional participation by F-Prime Capital and returning investor Thrive Capital.

BioTech 187
article thumbnail

AI biotech company Genesis scores $200M to advance drug discovery

Mobi Health News

The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.

BioTech 221